In-Silico Drug Discovery Market Report: Trends, Insights, and Forecast for 2030

The global In-Silico Drug Discovery Market is projected to grow to USD 4.07 billion by 2025 and reach USD 7.22 billion by 2030, with a CAGR of 12.2% from 2025 to 2030.

Download FREE Sample

 Growth is fueled by rising demand for AI-powered drug discovery, increased use of virtual clinical trials, and greater investments in computational biology, offering reduced development timelines, cost efficiency, and precise virtual simulations. North America leads the market, driven by significant R&D investments in the U.S. and Canada, supported by major pharmaceutical, biotechnology and Growth is fueled by rising demand for AI-powered drug discovery, increased use of virtual clinical trials, and greater investments in computational biology, offering reduced development timelines, cost efficiency, and precise virtual simulations. North America leads the market, driven by significant R&D investments in the U.S. and Canada, supported by major pharmaceutical, biotechnology, and AI-focused tech companies.